Logo image of CETX

CEMTREX INC (CETX) Stock Fundamental Analysis

USA - NASDAQ:CETX - US15130G8814 - Common Stock

5.26 USD
-0.23 (-4.19%)
Last: 10/27/2025, 8:08:44 PM
5.23 USD
-0.03 (-0.57%)
After Hours: 10/27/2025, 8:08:44 PM
Fundamental Rating

3

Taking everything into account, CETX scores 3 out of 10 in our fundamental rating. CETX was compared to 123 industry peers in the Electronic Equipment, Instruments & Components industry. CETX may be in some trouble as it scores bad on both profitability and health. CETX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CETX has reported negative net income.
CETX had a positive operating cash flow in the past year.
In the past 5 years CETX always reported negative net income.
In the past 5 years CETX always reported negative operating cash flow.
CETX Yearly Net Income VS EBIT VS OCF VS FCFCETX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

The Return On Assets of CETX (-43.62%) is worse than 79.67% of its industry peers.
CETX has a worse Return On Equity (-566.16%) than 95.12% of its industry peers.
The Return On Invested Capital of CETX (6.61%) is better than 67.48% of its industry peers.
Industry RankSector Rank
ROA -43.62%
ROE -566.16%
ROIC 6.61%
ROA(3y)-21.48%
ROA(5y)-19.29%
ROE(3y)-123.52%
ROE(5y)-88.57%
ROIC(3y)N/A
ROIC(5y)N/A
CETX Yearly ROA, ROE, ROICCETX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

The Operating Margin of CETX (2.50%) is comparable to the rest of the industry.
With a decent Gross Margin value of 43.13%, CETX is doing good in the industry, outperforming 75.61% of the companies in the same industry.
In the last couple of years the Gross Margin of CETX has remained more or less at the same level.
Industry RankSector Rank
OM 2.5%
PM (TTM) N/A
GM 43.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.38%
GM growth 5Y0.7%
CETX Yearly Profit, Operating, Gross MarginsCETX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CETX is still creating some value.
The number of shares outstanding for CETX has been reduced compared to 1 year ago.
The number of shares outstanding for CETX has been increased compared to 5 years ago.
Compared to 1 year ago, CETX has an improved debt to assets ratio.
CETX Yearly Shares OutstandingCETX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500 1K 1.5K
CETX Yearly Total Debt VS Total AssetsCETX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

CETX has an Altman-Z score of -0.94. This is a bad value and indicates that CETX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CETX (-0.94) is worse than 79.67% of its industry peers.
A Debt/Equity ratio of 2.40 is on the high side and indicates that CETX has dependencies on debt financing.
The Debt to Equity ratio of CETX (2.40) is worse than 94.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.4
Debt/FCF N/A
Altman-Z -0.94
ROIC/WACC1.33
WACC4.96%
CETX Yearly LT Debt VS Equity VS FCFCETX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

CETX has a Current Ratio of 1.20. This is a normal value and indicates that CETX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.20, CETX is not doing good in the industry: 84.55% of the companies in the same industry are doing better.
CETX has a Quick Ratio of 1.20. This is a bad value and indicates that CETX is not financially healthy enough and could expect problems in meeting its short term obligations.
CETX has a worse Quick ratio (0.96) than 77.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.96
CETX Yearly Current Assets VS Current LiabilitesCETX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 98.48% over the past year.
The Revenue has grown by 16.50% in the past year. This is quite good.
CETX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.21% yearly.
EPS 1Y (TTM)98.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.7%
Revenue 1Y (TTM)16.5%
Revenue growth 3Y15.76%
Revenue growth 5Y11.21%
Sales Q2Q%15.49%

3.2 Future

Based on estimates for the next years, CETX will show a very strong growth in Earnings Per Share. The EPS will grow by 89.28% on average per year.
CETX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.00% yearly.
EPS Next Y143.31%
EPS Next 2Y89.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2Y15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CETX Yearly Revenue VS EstimatesCETX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CETX Yearly EPS VS EstimatesCETX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2023 2024 2025 2026 0 200K -200K -400K

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CETX. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 2.57, which indicates a rather cheap valuation of CETX.
Based on the Price/Forward Earnings ratio, CETX is valued cheaper than 99.19% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.09, CETX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 2.57
CETX Price Earnings VS Forward Price EarningsCETX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CETX is valued cheaply inside the industry as 95.94% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.38
CETX Per share dataCETX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 -100 -150

4.3 Compensation for Growth

CETX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CETX's earnings are expected to grow with 89.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y89.28%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CETX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CEMTREX INC

NASDAQ:CETX (10/27/2025, 8:08:44 PM)

After market: 5.23 -0.03 (-0.57%)

5.26

-0.23 (-4.19%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-12 2025-08-12
Earnings (Next)12-29 2025-12-29/amc
Inst Owners1.57%
Inst Owner Change0%
Ins Owners0%
Ins Owner Change0%
Market Cap3.89M
Revenue(TTM)76.10M
Net Income(TTM)-20482600
Analysts82.86
Price TargetN/A
Short Float %N/A
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.57
P/S 0.05
P/FCF N/A
P/OCF 2.53
P/B 1.08
P/tB N/A
EV/EBITDA 5.38
EPS(TTM)-168.32
EYN/A
EPS(NY)2.05
Fwd EY38.98%
FCF(TTM)-1.03
FCFYN/A
OCF(TTM)2.08
OCFY39.51%
SpS102.83
BVpS4.89
TBVpS-0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -43.62%
ROE -566.16%
ROCE 8.44%
ROIC 6.61%
ROICexc 9.56%
ROICexgc 12.51%
OM 2.5%
PM (TTM) N/A
GM 43.13%
FCFM N/A
ROA(3y)-21.48%
ROA(5y)-19.29%
ROE(3y)-123.52%
ROE(5y)-88.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.38%
GM growth 5Y0.7%
F-Score5
Asset Turnover1.62
Health
Industry RankSector Rank
Debt/Equity 2.4
Debt/FCF N/A
Debt/EBITDA 2.72
Cap/Depr 178.45%
Cap/Sales 3.03%
Interest Coverage 0.96
Cash Conversion 48.14%
Profit Quality N/A
Current Ratio 1.2
Quick Ratio 0.96
Altman-Z -0.94
F-Score5
WACC4.96%
ROIC/WACC1.33
Cap/Depr(3y)155.23%
Cap/Depr(5y)125.9%
Cap/Sales(3y)3.42%
Cap/Sales(5y)3.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.7%
EPS Next Y143.31%
EPS Next 2Y89.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.5%
Revenue growth 3Y15.76%
Revenue growth 5Y11.21%
Sales Q2Q%15.49%
Revenue Next Year15%
Revenue Next 2Y15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y138.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y92.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y118.35%
OCF growth 3YN/A
OCF growth 5YN/A

CEMTREX INC / CETX FAQ

Can you provide the ChartMill fundamental rating for CEMTREX INC?

ChartMill assigns a fundamental rating of 3 / 10 to CETX.


What is the valuation status of CEMTREX INC (CETX) stock?

ChartMill assigns a valuation rating of 5 / 10 to CEMTREX INC (CETX). This can be considered as Fairly Valued.


What is the profitability of CETX stock?

CEMTREX INC (CETX) has a profitability rating of 2 / 10.


What is the financial health of CEMTREX INC (CETX) stock?

The financial health rating of CEMTREX INC (CETX) is 2 / 10.